Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DNA Methylation as a Predictor for Response and Progression-Free Survival in Patients With Ovarian Cancer

NCT00900289 is registered in ClinicalTrials.gov with Liz-Anne Lewsley as lead sponsor.

NCT NCT00900289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00900289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DNA Methylation as a Predictor for Response and Progression-Free Survival in Patients With Ovarian Cancer
Lead sponsor
Liz-Anne Lewsley
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2002
Completion date
Not reported
Enrollment
1,000 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer